Care Management


Overall, both case management (CM) and disease management (DM) are vital to reduce healthcare costs by helping beneficiaries control their disease and prevent excessive utilization. However, there are differences in their approach.
Panelists Peter L. Salgo, MD; Jonathan Silverberg, MD, PhD, MPH; Jeffrey D. Dunn, PharmD, MBA; Cheryl Allen, BS Pharm, MBA; and Ed Pezalla, MD, MPH, discuss determining and recognizing utilization management for long-term systemic therapies in patients with atopic dermatitis.
Most internal medicine subspecialists report the majority of their clinical time is spent in principal care or longitudinal consultative care patient management roles.
Steven Peskin, MD, MBA, FACP, executive director of Population Health of Horizon Blue Cross Blue Shield of New Jersey, discusses managed care’s current approach to reimbursements for the clinical advancements in the treatment of multiple myeloma, given the current lack of care management pathways available to guide physicians regarding treatment decisions.
Derek van Amerongen, MD, MS, describes the importance of nursing care and specialty pharmacy services for managing patients with pulmonary arterial hypertension.


October 17 - 18, 2014
Boston, MA
COPD Compendium
Diabetes Compendium
MACRA Compendium
Oncology Compendium
Rare Disease Compendium
Reimbursement Compendium
Know Your News
HF Compendium